Hi HAIFer!
I know exactly what you’re thinking: Another one? First it was OpenAI, then Claude, and now Amazon. We haven’t even hit the end of January, and the AI arms race is already in overdrive.
Tomorrow, I’m headed to LinkedIn to share a full side-by-side comparison of how they all stack up. If you haven’t yet, turn on notifications on my profile here so you don’t miss the breakdown. I always love hearing your perspective, so keep an eye out - I can’t wait to hear what you think!
Your shortcut for this week:
Read on for the foresight of the week and the full breakdown of what shaped healthcare AI 👇
Solutions and Launches
Amazon One Medical (US): Deployed an agentic AI assistant with write access to execute tasks including booking, refills, and triage. This system marks a pivot from information retrieval to autonomous care coordination. [Link]

John Snow Labs (US): Launched the "Patient Journey Intelligence" platform to satisfy new FDA real-world evidence requirements. It utilizes medical LLMs to extract auditable facts from unstructured notes, solving the "black box" lineage problem for regulatory submissions. [Link]
Ant Group (China): Upgraded its "AQ" platform with DeepSearch, a clinical tool indexing 36M publications. It provides doctors with evidence-graded, guideline-aligned answers to ensure accuracy over generative guesswork. [Link]
Governance, Policy, and Ethics
ECRI (US): Officially designated "Misuse of AI Chatbots" as the #1 health technology hazard for 2026. The safety organization warns that unregulated use of LLMs by patients and staff is leading to incorrect diagnoses and dangerous medical errors. [Link]
NHS England (UK): Approved 19 AI notetaking tools, citing a 23.5% gain in patient interaction. The BMA called the rollout "impulsive," warning that MHRA safety regulations are still pending. [Link]
EU Data Protection Board (EU): Warned that the new "Digital Omnibus" proposal to simplify AI Act compliance must not compromise fundamental rights, specifically rejecting the removal of registration requirements for high-risk systems. [Link]
WHO & IPU (Global): Framed AI-amplified misinformation as a critical parliamentary issue. A new briefing highlights how legislators must shape legal frameworks to hold platforms accountable for algorithms that disproportionately mislead women and youth. [Link]
Research and AI Advancements
HealthContradict: Evaluating biomedical knowledge conflicts in language models: Introduced a benchmark of 920 expert-verified instances to test how LLMs handle contradictory evidence, measuring their ability to resist incorrect context when presented with conflicting medical data [Link]
Nature Digital Medicine (Tanzania): Validated an EMR-fine-tuned LLM for predicting HIV care disengagement. [Link]

Partnerships & Adoption
Qualified Health & Anthropic (US): Deployed the Claude model at UTMB to identify care gaps. The system reviews cardiology records to flag patients missing guideline-directed therapies, moving LLMs into population health management. [Link]
Innovaccer & Coforge (US/Global): Released "G-Forge," a joint initiative to help healthcare organizations scale AI. [Link]
Gates Foundation & OpenAI (Global): Initiated "Horizon 1000," a $50M infrastructure project. Rather than dropping tools into clinics, they are building the operational layer to support AI assistants in 1,000 African primary care clinics by 2028. [Link]
NHS Suffolk & North East Essex ICB (UK): An independent evaluation of Nobi smart lights across care homes confirmed they reduced fall-related hospital visits by up to 75%, validating the impact of ambient sensing on reducing emergency admissions. [Link]
Zain KSA & Altibbi (Saudi Arabia): Launched "Zain Clinic," embedding 24/7 telehealth and digital prescriptions directly into the telecom operator's existing app to instantly scale access to millions of subscribers. [Link]

World Economic Forum & CEPI (Global): Launched the "Pandemic Preparedness Engine" (PPX) at Davos. This agentic platform compresses vaccine target identification from months to days by treating biological surveillance as a continuous data problem. [Link]
Bets on the Next Health System
Investments:
OpenEvidence (US): Secured $250M Series D at a $12B valuation. The funding supports its "medical copilot," which is trained solely on medical journals to provide doctors with evidence-based clinical decision support. [Link]
Oviva (Europe): Raised €200M to expand its AI-assisted chronic care platform. Already fully reimbursed in systems like the NHS and DiGA, the funding will scale its "human-in-the-loop" programs for obesity and diabetes. [Link]
Eolas Medical (UK): A Belfast-based startup already deployed in 400+ UK clinical sites, Eolas raised $12M to organize unstructured hospital protocols into a centralized, AI-searchable knowledge base. [Link]
M&A:
Serve Robotics (US): Acquired Diligent Robotics for $29M to enter the healthcare market. [Link]
Tandem Health (Sweden): Acquired Dutch AI scribe leader Juvoly to expand its European footprint. The deal integrates Juvoly’s 1,500 GP users and specialized Dutch-language models into Tandem's platform. [Link]
That’s a wrap for Edition #16 of Health AI Foresight.
My goal with this newsletter is simple - to connect the present, the emerging, and the future of healthcare AI.
See you next week.
- Dr. Aboufandi
📩 Something stand out? Or have a suggestion? Hit reply - I read every message.

